AUTOIMMUNE DISEASES

This study looked at how well the seasonal and H1N1 flu vaccine works and how safe it is for people with autoimmune diseases like lupus or vasculitis. Researchers measured antibody levels three weeks after each shot. The goal was to see if the vaccine provides protection even in …

This early-stage study tested a new drug called VIS171 in 61 people, first in healthy volunteers and then in patients with autoimmune diseases. The main goal was to check safety and how the body processes the drug. Results will help decide if further testing is warranted.

This study tested the safety and effectiveness of a medical device called GLOBAFFIN® in 34 adults with autoimmune diseases. The device filters harmful antibodies from the blood to help control the disease. The main goal was to measure how much antibody levels dropped after each t…

This study looked at whether taking daily vitamin D or fish oil supplements could lower the risk of autoimmune diseases (like rheumatoid arthritis), reduce signs of inflammation in the blood, and ease chronic knee pain. Over 25,000 adults without prior cancer or heart disease too…

This study tested a new antibody drug (C5 monoclonal antibody) in 16 people with anti-GBM disease, a severe autoimmune condition that attacks the kidneys. The goal was to see if the drug could prevent kidney failure better than current treatments. The approach targets part of the…

This study tested a combined bone marrow and kidney transplant from a partially matched related donor for 10 people with both a blood disorder and chronic kidney disease. The goal was to treat both conditions and possibly reduce the need for lifelong anti-rejection drugs after th…

This study tested a non-invasive treatment called transcutaneous electrical acupoint stimulation (TEAS) for period pain in 52 women with rheumatoid arthritis or lupus. Participants received either TEAS or a placebo, and researchers measured pain, walking speed, and inflammation m…

This study followed 80 people with pemphigus, a severe autoimmune blistering skin disease, who had previously taken part in a trial of the drug rituximab. Researchers wanted to see how safe the drug is over many years, how often the disease returns, and how the immune system chan…

This study followed 73 people with autoimmune diseases like rheumatoid arthritis or multiple sclerosis who were starting treatment with rituximab, a drug that suppresses the immune system. The goal was to track how many developed serious infections and identify who was most at ri…

This study tested whether coaching sessions are a practical way to help young people with rheumatic diseases (like juvenile arthritis) move from pediatric to adult rheumatology care. Researchers enrolled 26 patients and measured how many agreed to join, attended sessions, and com…

This study looked at whether a diet low in salt and sugar can reduce common side effects of corticosteroid treatment, like weight gain, high blood pressure, and diabetes. Fifty adults with autoimmune diseases or asthma who were starting high-dose steroids participated. Researcher…

This early-stage study tested the safety and how the body handles a new drug called RLYB116 in 16 healthy adults aged 18 to 55. Participants received multiple doses, and researchers monitored side effects, drug levels, and immune reactions. The goal was to gather safety informati…

This study tested specially engineered versions of a natural immune protein (IL-2) in blood samples from 67 people with autoimmune or inflammatory diseases like lupus, multiple sclerosis, and rheumatoid arthritis. The goal was to see if these modified proteins could selectively a…